Literature DB >> 25375899

Exceptionally low rotavirus incidence in the Netherlands in 2013/14 in the absence of rotavirus vaccination.

S Hahné1, M Hooiveld, H Vennema, A van Ginkel, H de Melker, J Wallinga, W van Pelt, P Bruijning-Verhagen.   

Abstract

An unexpected drop in rotavirus (RV) detections was observed in the Netherlands in 2014, without RV vaccination. The estimated decrease in RV detections and gastroenteritis consultations in under five year-olds, in January-April 2014, compared to the same months in previous years, was 72% and 36%, respectively. The low birth rate, mild winter, high RV incidence in the previous year and the introduction of RV vaccination in neighbouring countries may have contributed to this decrease.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25375899     DOI： 10.2807/1560-7917.es2014.19.43.20945

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  12 in total

1.  Introduction of a new Rotavirus vaccine: Initial results of uptake and impact on laboratory confirmed cases in Anglia and Essex, United Kingdom, July 2015.

Authors:  Thomas Inns; Amy Trindall; Sara Dunling-Hall; Ananda Giri Shankar
Journal:  Hum Vaccin Immunother       Date:  2015-11-30       Impact factor: 3.452

2.  The impact of publicly funded rotavirus immunization programs on Canadian children.

Authors:  Pia K Muchaal; Matt Hurst; Shalini Desai
Journal:  Can Commun Dis Rep       Date:  2021-03-04

3.  Characteristics of child daycare centres associated with clustering of major enteropathogens.

Authors:  R Pijnacker; L Mughini-Gras; H Vennema; R Enserink; C C VAN DEN Wijngaard; T Kortbeek; W VAN Pelt
Journal:  Epidemiol Infect       Date:  2016-09       Impact factor: 4.434

4.  Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium?

Authors:  Virginia E Pitzer; Joke Bilcke; Elisabeth Heylen; Forrest W Crawford; Michael Callens; Frank De Smet; Marc Van Ranst; Mark Zeller; Jelle Matthijnssens
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

5.  Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted.

Authors:  Sara L Thomas; Jemma L Walker; Justin Fenty; Katherine E Atkins; Alex J Elliot; Helen E Hughes; Julia Stowe; Shamez Ladhani; Nick J Andrews
Journal:  Vaccine       Date:  2016-12-20       Impact factor: 3.641

6.  Secular trends in incidence of acute gastroenteritis in general practice, France, 1991 to 2015.

Authors:  Mathieu Rivière; Noémie Baroux; Vanina Bousquet; Katia Ambert-Balay; Pascal Beaudeau; Nathalie Jourdan-Da Silva; Dieter Van Cauteren; Frédéric Bounoure; Fanny Cahuzac; Thierry Blanchon; Thierry Prazuck; Clément Turbelin; Thomas Hanslik
Journal:  Euro Surveill       Date:  2017-12

7.  Determinants of Rotavirus Transmission: A Lag Nonlinear Time Series Analysis.

Authors:  Rolina D van Gaalen; Jan van de Kassteele; Susan J M Hahné; Patricia Bruijning-Verhagen; Jacco Wallinga
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

8.  Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.

Authors:  P Bruijning-Verhagen; J A P van Dongen; J D M Verberk; R Pijnacker; R D van Gaalen; D Klinkenberg; H E de Melker; M-J J Mangen
Journal:  BMC Med       Date:  2018-09-10       Impact factor: 8.775

9.  Epidemiological trends for hospital admissions for acute rotavirus gastroenteritis in Belgium following the introduction of routine rotavirus vaccination and the subsequent switch from lyophilized to liquid formulation of Rotarix™.

Authors:  M Raes; D Strens; J Kleintjens; E Biundo; T Morel; A Vyse
Journal:  Epidemiol Infect       Date:  2016-07-04       Impact factor: 2.451

10.  Universal rotavirus vaccination program in Sicily: Reduction in health burden and cost despite low vaccination coverage.

Authors:  Claudio Costantino; Vincenzo Restivo; Fabio Tramuto; Alessandra Casuccio; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2018-06-22       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.